Fundamental Analysis of Teva Pharma Industries Ltd. - Growth / Value Index
TEVA - Valuation Highlights
Valuation Analysis
Book Value in last 3 years is trending down
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | -37.35 | -32.61 | -324.34 % | |
| Price to Book | 2.33 | 2.24 | 7.82 % | 2.47 |
| Price to Sales | 1.15 | 1.15 | -5.05 % | |
| Enterprise Value to EBITDA Multiple | 12.28 | 80.45 | 471.03 % |
TEVA - Profitability Highlights
Profitability Analysis
Piotroski F Score - Stable Value of 4.0
Tsr Profitability Index - Very Poor Score of 5.00
Negative Net profit for last two years
In the last three years, the company has given poor Net Margin
In the last three years, the company has given poor Returns on Equity
In the last three years, the company has given poor Returns on Assets
Negative Net Margin MRQ
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | -6.55 | -7.45 | 72.49 % | -1.84 |
| Return On Asset | -1.15 | -1.29 | 75.96 % | -0.325 |
| Net Profit Margin | -3.08 | -3.53 | 77.62 % | -3.64 |
| Operating Profit Margin | 3.82 | 2.73 | 119.43 % | -5.71 |
| EBITDA Margin | 17.84 | 2.73 | 124.23 % | -5.71 |
Highlights
| Market Cap | 18450.71 M |
| Enterprise Value | 35057.71 M |
| Price/Book TTM | 2.33 |
| Outstanding Share | 1132.64 M |
| Float/ Outstanding Share | 99.40% |
| Dividend Yield | 2.29 % |
Share Holding
Guru Numbers
| Price/Graham No | 0 |
| Peter Lynch Ratio | 0 |
| Piotroski F Score | 4.00 |
| Altman Z Score | 0.194 |
| Sloan Ratio | -0.0443 |
| Peter Lynch Fair Value | 0 |
TEVA - Growth Highlights
Growth Analysis
Tsr Growth Index - Poor Score of 34.14
Company's Total Assets is Decreasing for last 3 years
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 16004.00 M | 6.17 % | 14.31 % |
| Gross Profit | 7834.00 M | 9.64 % | 26.70 % |
| EBITDA | 2855.00 M | 125.73 % | 115.02 % |
| Net Profit | -493000.00 K | 76.24 % | 132.40 % |
| EPS | -0.436 | 76.43 % | NA |
TEVA - Stability Highlights
Stability Analysis
Tsr Stability Index - Very Poor Score of 7.81
Altman Z Score of 0.209 suggest high risk
Company has high debt burden
Interest Coverage of -0.700
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 2.64 | 8.26 % | 2.60 |
| Cash Ratio | 0.263 | 7.86 % | |
| Quick Ratio | 0.691 | -3.55 % | 0.605 |
| Shareholders Equity | 17.26 | -12.59 % | |
| Debt to EBITDA | 45.80 | 463.42 % |
Historical Valuation Ratios of Teva Pharma Industries Ltd.
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Teva Pharma Industries Ltd.
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Teva Pharma Industries Ltd.
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Teva Pharma Industries Ltd.
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)